Role of TPD52 in Endometrial Cancer: Impact on EMT and the PI3K/AKT and ERK/MAPK Signaling
TPD52 promotes EC progression through EMT and PI3K/AKT and ERK/MAPK activation, offering a promising therapeutic target whose clinical utility warrants further investigation.
Authors
- Buze Chen (ORCID: https://orcid.org/0000-0002-3864-6910)
- Jing Li (ORCID: https://orcid.org/0000-0002-4202-2297)
- Lin Li (ORCID: https://orcid.org/0000-0002-8014-8296)
- Miao Lu (ORCID: https://orcid.org/0000-0002-4490-2087)
- Binlin Ma (ORCID: https://orcid.org/0000-0002-1272-7261)
Institutions
- Xuzhou Medical College (CN)
Publication Details
- Journal
- Protein and Peptide Letters
- Published
- 2025-10-26
- DOI
- https://doi.org/10.2174/0109298665400400251003013958
- Citations
- 2
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.11